You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Immunization Against COVID-19 (QC01.9 code is in compliance with ICD-11)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Immunization Against COVID-19 Trial in Russian Federation (Ergoferon, Placebo)

Completed
  • Immunization Against COVID-19
  • Belgorod, Russian Federation
  • +32 more
Apr 21, 2022

COVID-19 Pandemic Trial in China (SCTV01E, Placebo (normal saline))

Recruiting
  • COVID-19 Pandemic
  • SCTV01E
  • Placebo (normal saline)
  • Lianshui, Jiangsu, China
  • +3 more
Jan 5, 2023

COVID-19 Trial in Huai'an (COVID-19 Vaccine (Vero cell), Inactivated (Omicron variant), COVID-19 Vaccine (Vero cell),

Recruiting
  • COVID-19
  • COVID-19 Vaccine (Vero cell), Inactivated (Omicron variant)
  • COVID-19 Vaccine (Vero cell), Inactivated (CZ strain)
  • Huai'an, Jiangsu, China
    Huaiyin Center for Disease Control and Prevention
Jan 11, 2023

COVID-19, Vaccines Trial in Los Angeles (Reminder to boost protection against COVID-19, Flu Tag Along, COVID-19 Booster & Flu

Recruiting
  • COVID-19
  • Vaccines
  • Reminder to boost protection against COVID-19
  • +2 more
  • Los Angeles, California
    UCLA Health Department of Medicine, Quality Office
Nov 4, 2022

Against Hospitalizations Due to Circulating COVID-19 VoC RWE

Recruiting
  • COVID-19, SARS-CoV-2
    • Argentina, Buenos Aires, Argentina
    • +12 more
    Dec 27, 2022

    Coronavirus, Coronavirus Infection, Coronavirus as the Cause of Diseases Classified Elsewhere Trial in Los Angeles, Bryan,

    Active, not recruiting
    • Coronavirus
    • +2 more
    • BCG Vaccine
    • Placebo Vaccine
    • Los Angeles, California
    • +5 more
    Oct 18, 2022

    SARS-CoV-2 Infection Trial in Mexico City (Recombinant NDV Vectored Vaccine for SARS-CoV-2)

    Completed
    • SARS-CoV-2 Infection
    • Recombinant NDV Vectored Vaccine for SARS-CoV-2
    • Mexico City, Ciudad De Mexico, Mexico
      Hospital Medica Sur
    Dec 8, 2022

    COVID-19 Trial in Edison (Omega-3 (EPA+DHA), Placebo)

    Recruiting
    • COVID-19
    • Omega-3 (EPA+DHA)
    • Placebo
    • Edison, New Jersey
      Hackensack Meridian Health
    Dec 13, 2022

    COVID-19 Vaccines Using Information From California State

    Not yet recruiting
    • SARS-CoV-2
    • +2 more
    • Pfizer-BioNTech COVID-19 bivalent mRNA vaccine
    • (no location specified)
    May 23, 2023

    Immunosuppressants to Postoperative Infection and Death

    Recruiting
    • Organ Transplantation
    • +2 more
    • Immunosuppressive Agents
    • Taichung, Taiwan
      Chung Shan Medical University
    Nov 6, 2023

    A Study of the Effectiveness of Moderna COVID-19 Vaccine

    Recruiting
    • SARS-CoV-2
    • COVID-19
    • mRNA-1273
    • Pasadena, California
      Kaiser Permanente Southern California
    Jul 5, 2023

    COVID-19 Trial in Weihai (Inactivated COVID-19 Vaccine)

    Active, not recruiting
    • COVID-19
    • Inactivated COVID-19 Vaccine
    • Weihai, Shandong, China
      Rushan City Center for Disease Control and Prevention
    Jul 11, 2022

    COVID-19 Vaccines Trial in Rio de janeiro

    Recruiting
    • COVID-19 Vaccines
      • Rio de janeiro, Brazil
        Instituto de Tecnologia em Imunobiológicos Bio-Manguinhos/Fiocru
      Nov 17, 2022

      SARS-CoV-2 Infection Trial in Mexico (AVX-COVID/12, ChAdOx-1-S[recombinant])

      Recruiting
      • SARS-CoV-2 Infection
      • AVX-COVID/12
      • ChAdOx-1-S[recombinant]
      • Mexico City, Cdmx, Mexico
      • +13 more
      Feb 3, 2023

      COVID-19 Disease & Vaccine Survey in Africa

      Recruiting
      • COVID-19
      • Vaccine Hesitancy
      • Questionnaire
      • Surrey, British Columbia, Canada
        Salem Anaesthesia Pain Clinic
      Jul 18, 2023

      Effect of COVID-19 Pandemic on Vaccination Compliance

      Not yet recruiting
      • Vaccine Refusal
      • vaccine
      • (no location specified)
      Jul 30, 2021

      Main Preventive Health Campaigns of Persons With Multiple

      Recruiting
      • Multiple Sclerosis
      • phone interview
      • Ferrara, FE, Italy
      • +11 more
      Nov 15, 2022

      COVID-19 Pneumonia, Coronavirus Infections Trial in Seha (Recombinant COVID-19 Vaccine (CHO cell,NVSI-06-08), Inactivated

      Recruiting
      • COVID-19 Pneumonia
      • Coronavirus Infections
      • Recombinant COVID-19 Vaccine (CHO cell，NVSI-06-08)
      • +2 more
      • Seha, Abu Dhab, United Arab Emirates
        Sheikh Khalifa Medical City
      Jan 30, 2023

      COVID-19, Vaccine-Preventable Diseases, SARS CoV 2 Infection Trial (Novavax COVID-19 vaccine (2023-2024 formula XBB containing),

      Not yet recruiting
      • COVID-19
      • +4 more
      • Novavax COVID-19 vaccine (2023-2024 formula XBB containing)
      • Pfizer COVID-19 mRNA vaccine (2023-2024 formula XBB containing)
      • (no location specified)
      Sep 29, 2023

      Against Sars-Cov2 Virus in Received EU-approved COVID-19

      Completed
      • SARS-CoV2 Infection
      • Vaccine Reaction
      • Approved vaccines against Sars-Cov2
      • Patras, Greece
        University Hospital of Patras
      Jun 2, 2022

      COVID-19 Pandemic Trial in Malaysia, Pakistan (Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01), Blank Preparation of

      Active, not recruiting
      • COVID-19 Pandemic
      • Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01)
      • Blank Preparation of Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01)
      • Kuching, Sarawak, Malaysia
      • +17 more
      Aug 31, 2022

      Under Invasive Mechanical Ventilation in SARS-CoV-2 &

      Not yet recruiting
      • ARDS Due to Disease Caused by SARS Co-V-2
      • +2 more
        • (no location specified)
        Feb 1, 2023

        Long COVID, POTS - Postural Orthostatic Tachycardia Syndrome, Autonomic Dysfunction Trial (IL-6, cytokines (IL-17, and IFN-?),

        Not yet recruiting
        • Long COVID
        • +2 more
        • IL-6
        • +2 more
        • (no location specified)
        Sep 6, 2023

        Study of the Effectiveness of The COVID-19 Vaccine

        Completed
        • COVID-19
        • COVID-19 Antibody
        • Sukoharjo, Central Java, Indonesia
          Universitas Sebelas Maret Hospital
        Mar 9, 2023

        Immunogenicity and Safety of a Recombinant Adenovirus Type-5-vectored COVID-19 Vaccine Using for Sequential Immunization Trial

        Recruiting
        • Immunogenicity and Safety of a Recombinant Adenovirus Type-5-vectored COVID-19 Vaccine Using for Sequential Immunization
        • Recombinant adenovirus type-5-vectored COVID-19 vaccine
        • Hangzhou, Zhejiang, China
          Xihu District Center for Disease Control and Prevention
        May 12, 2022